Indication
E. coli lung abscess
An *Escherichia coli* lung abscess is a severe, necrotizing pulmonary infection characterized by the formation of one or more pus-filled cavitary lesions within the lung parenchyma caused by the Gram-negative bacillus *E. Read more about E. coli lung abscess
13 drugs 13 manufacturers
Drugs that treat it
Common E. coli lung abscess therapies.
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn *Escherichia coli* lung abscess is a severe, necrotizing pulmonary infection characterized by the formation of one or more pus-filled cavitary lesions within the lung parenchyma caused by the Gram-negative bacillus *E.
coli*.
Typically affecting the lower respiratory tract, it predominantly occurs in hospitalized, debilitated, or immunocompromised patients, as well as individuals predisposed to aspiration of gastrointestinal secretions or hematogenous seeding from an extrapulmonary focus, such as a urinary tract or intra-abdominal infection.
Pathophysiologically, the organism incites intense local inflammation leading to liquefactive tissue necrosis, cavity formation, and air-fluid levels visible on chest imaging.
Patients commonly present with productive cough yielding purulent or foul-smelling sputum, high fever, chills, pleuritic chest pain, leukocytosis, and constitutional symptoms like fatigue and weight loss.
- merckmanuals.com
An *Escherichia coli* lung abscess is a severe, necrotizing pulmonary infection characterized by the formation of one or more pus-filled cavitary lesions within the lung parenchyma caused by the Gram-negative bacillus *E. coli* Typically affecting the lower respiratory tract, it predominantly occurs in hospitalized, debilitated, or immunocompromised patients, as well as individuals predisposed to aspiration of gastrointestinal secretions or hematogenous seeding from an extrapulmonary focus, such...
- medwinpublishers.com
Typically affecting the lower respiratory tract, it predominantly occurs in hospitalized, debilitated, or immunocompromised patients, as well as individuals predisposed to aspiration of gastrointestinal secretions or hematogenous seeding from an extrapulmonary focus, such as a urinary tract or intra-abdominal infection
- sma.org.sg
Pathophysiologically, the organism incites intense local inflammation leading to liquefactive tissue necrosis, cavity formation, and air-fluid levels visible on chest imaging Patients commonly present with productive cough yielding purulent or foul-smelling sputum, high fever, chills, pleuritic chest pain, leukocytosis, and constitutional symptoms like fatigue and weight loss
Personalize your experience
Follow E. coli lung abscess and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.